New York Health Care, Inc.
New York Health Care, Inc. (BBAL) PE Ratio — Current & Historical Data
Trailing twelve months (TTM) P/E, forward P/E, PEG, and annual PE history — from market prices and filings.
bbal · pe ratio · data through Dec 31, 2007
Core PE Ratio Metrics
Trailing 12 months · TTMThe price-to-earnings (P/E) ratio for New York Health Care, Inc. (BBAL) measures how much investors pay for each dollar of the company's trailing earnings. BBAL's current PE ratio of N/A is calculated by dividing its stock price of $0.00 by its TTM earnings per share of -$0.03.
Source: FMP · /ratios-ttm · /analyst-estimates · 2007-12-31
PE Ratio History
1996 – 2007 · Annual▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare (Annual)
Historical PE Range
Past 4 fiscal years · Front-end computedMinQ1 · 25%29.6x
MedianQ3 · 75%35.1x
Max
At N/A, BBAL's current P/E is lower than in 0% of its annual fiscal year readings over the past 4 years — historically low.
Percentile calculated from annual fiscal year data points, not by trading day. Years where PE ≤ 0 or > 9,999 are excluded.
PE Ratio vs Peers
Medical - Care Facilities · 6 peers · Annual PE| Company | Market Cap | PE (Annual) | vs Avg | EPS (TTM) |
|---|---|---|---|---|
New York Health Care, Inc.You BBAL | $0M | N/A | — | -$0.03 |
 Comera Life Sciences Holdings, Inc. CMRA | $0M | N/A | — | -$1.72 |
 FluoroPharma Medical, Inc. FPMI | $0M | N/A | — | -$0.06 |
 Net Medical Xpress Solutions, Inc. NMXS | $0M | N/A | — | -$0.05 |
 NewCardio, Inc. NWCI | $0M | N/A | — | -$0.40 |
 PAO Group, Inc. PAOG | $0M | N/A | — | -$0.00 |
 Rebus Holdings, Inc. RBSH | $0M | N/A | — | -$0.03 |
* N/A — Company is not profitable (TTM) · excluded from industry average · ▸ FMP /stock-peers + /ratios?limit=1 · priceToEarningsRatio
Annual PE Ratio History
| Fiscal Year End | PE Ratio | EPS (TTM) | YoY Change | PE vs Max |
|---|---|---|---|---|
2007-12-31Latest FY2007 | — | $-0.03 | — | |
2006-12-31 FY2006 | — | $-0.11 | — | |
2005-12-31 FY2005 | — | $-0.20 | — | |
2004-12-31 FY2004 | — | $-0.24 | — | |
2003-12-31 FY2003 | — | $-0.91 | — | |
2002-12-31 FY2002 | — | $-0.07 | — | |
2001-12-31 FY2001 | 35.05x | $0.14 | — | |
2000-12-31 FY2000 | — | $-0.49 | — | |
1999-12-31 FY1999 | — | $-0.06 | — | |
1998-12-31 FY1998 | 16.67x | $0.09 | -50.6% |
▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare · Zero extra API
About PE Ratio & Methodology
The price-to-earnings (P/E) ratio for New York Health Care, Inc. (BBAL) measures how much investors pay for each dollar of the company's trailing earnings. BBAL's current PE ratio of N/A is calculated by dividing its stock price of $0.00 by its TTM earnings per share of -$0.03.
Frequently asked questions
BBAL pe ratio · 6 questionsBBAL's current PE ratio is N/A as of 2026-06-09, based on a stock price of $0.00 and TTM EPS of -$0.03. Data sourced from Financial Modeling Prep via BBAL's SEC 10-K and 10-Q filings.
▸ Source: FMP · /ratios-ttm · /ratios annual · /analyst-estimates · /stock-peers · New York Health Care, Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: 2026-06-09